Syn-Coll
What do these badges mean?
Evidence tier
- AHuman-validated — Human trials showing positive results and good safety.
- BAnimal-grade — No human trials yet, but solid animal/preclinical evidence of effect and safety.
- CAnecdotal — No human or animal trials — only anecdotal/observational reports.
- DInsufficient evidence — No or insufficient evidence (encyclopedia only — never recommended by the builder).
Safety light
- 🟢 Green — Only mild, manageable side effects; reasonable safety data.
- 🟡 Yellow — Needs active management, has a meaningful contraindication/interaction, or has thin long-term data.
- 🔴 Red — Risk of a hospital-level event — treat with serious caution.
Browse-only — not on the protocol builder's curated shortlist, so the builder won't recommend it.
What is it?
Syn-Coll is a matrikine cosmetic peptide in the same collagen-signaling family as Matrixyl, Rigin, Tripeptide-29, and Palmitoyl Dipeptide-6.
What does it do in my body?
Syn-Coll mimics the active site of thrombospondin-1, activating latent TGF-β and triggering downstream collagen I and III synthesis in dermal fibroblasts.
How can it help me?
- Where the science stands: Anecdotal: 0 studies, 0 human trials
The full evidence — every human, animal, and lab study, graded — is one tap away: use the See the deeper science → toggle at the top.
Is it dangerous? What are the side effects?
No adverse-effect data specific to Syn-Coll was captured in the source profile. Family-wide read: topical delivery carries a benign safety record.
Regulatory status: Cosmetic-grade OTC topical ingredient — not an FDA-reviewed drug.
Typical dosing
Educational context only — talk to a licensed medical provider before any protocol. What follows describes the doses and schedules most commonly reported in the research and by practitioners, shared so you can have an informed conversation. These compounds are sold for research use only, are not FDA-approved drugs, and this is not medical advice.
Topical-only cosmetic ingredient. No specific concentration or use-frequency figure was captured in the source profile.
What should I avoid combining — and what's synergistic?
Syn-Coll doesn't have a dedicated stacking protocol in our notes — the interactions that matter most are in the safety section above. For how people combine it with other peptides, the deeper-science view has the full detail.
Where do people source this?
OHM does not sell or handle any compound. Research-use-only material is sold by third-party vendors; our vetting notes and disclosures are on the Where to buy page. If you'd rather have a physician in the loop, see the telehealth option. Whatever the route, the supply chain is the real risk: only consider vendors that publish batch-level third-party Certificates of Analysis.
A clean mechanistic story — activates the same growth-factor pathway (TGF-β) that drives collagen production — with no published efficacy data behind it yet.
| Class | Matrikine / collagen-signaling peptide — topical cosmetic peptide |
| Mechanism (one line) | Mimics the active site of thrombospondin-1 → activates latent TGF-β → triggers collagen I/III synthesis in dermal fibroblasts |
| Evidence base | Anecdotal: 0 studies, 0 human trials |
| Safety record | Topical-only; benign safety record (Safety: green) |
| Regulatory status | Cosmetic-grade OTC skincare ingredient, not an FDA-reviewed drug |
What it is
Syn-Coll is a matrikine cosmetic peptide in the same collagen-signaling family as Matrixyl, Rigin, Tripeptide-29, and Palmitoyl Dipeptide-6.
How it works
Syn-Coll mimics the active site of thrombospondin-1, activating latent TGF-β and triggering downstream collagen I and III synthesis in dermal fibroblasts.
What the research shows
Public profile grade: Anecdotal — 0 studies, 0 human trials. OHM’s internal 0035 categorization pass keeps Syn-Coll at Tier D / provisional (encyclopedia-only).
Honest status: clean mechanistic story (TGF-β activation), no published efficacy data.
Real-world protocol
Topical-only cosmetic ingredient. No specific concentration or use-frequency figure was captured in the source profile.
Side effects & management
No adverse-effect data specific to Syn-Coll was captured in the source profile. Family-wide read: topical delivery carries a benign safety record.
Regulatory status
Cosmetic-grade OTC topical ingredient — not an FDA-reviewed drug.
Sources
- (thepeptidelist.com directory, captured 2026-06-07) — profile grade: Anecdotal, 0 studies, 0 human trials.
- OHM tier/safety grading: Tier D / provisional (encyclopedia-only).
- Migrated from
cosmetic-topical-peptides-cluster.md(2026-06-10 cluster build) as part of the cluster-to-standalone-article migration.
Related: Matrixyl · Rigin · Tripeptide-29 · Palmitoyl Dipeptide-6
Sources & references
- (thepeptidelist.com directory, captured 2026-06-07) — profile grade: Anecdotal, 0 studies, 0 human trials.
- OHM tier/safety grading: Tier D / provisional (encyclopedia-only).
- Migrated from
cosmetic-topical-peptides-cluster.md(2026-06-10 cluster build) as part of the cluster-to-standalone-article migration.
Related: Matrixyl · Rigin · Tripeptide-29 · Palmitoyl Dipeptide-6